Fourier transform infrared spectroscopy and metabolic profiling in lung cancer

P. Kloer; R. Ghosal; Luis Alejandro Jose Mur; K. E. Lewis; P. D. Lewis

Fourier transform infrared spectroscopy and metabolic profiling in lung cancer

P. Kloer, R. Ghosal, Luis Alejandro Jose Mur, K. E. Lewis, P. D. Lewis

Adran y Gwyddorau Bywyd

Allbwn ymchwil: Pennod mewn Llyfr/Adroddiad/Trafodion Cynhadledd › Trafodion Cynhadledd (Nid-Cyfnodolyn fathau)

Crynodeb

Introduction: We have shown that sputum is a feasible biofluid for analysis of biomarkers using Fourier transform infrared (FTIR) spectroscopic analysis and that FTIR can detect different patterns of metabolites between patients with lung cancer and healthy volunteers.1 Aim: To analyse further the FTIR spectrometric patterns in more patients with lung cancer and also smokers deemed 'high risk'. To identify what actual compounds may differentiate cancer from non-cancer sputum samples. Methods: Loco-regional ethical permission was obtained.

Iaith wreiddiol	Saesneg
Teitl	Winter Meeting of the British-Thoracic-Society
Tudalennau	A60-A61
Statws	Cyhoeddwyd - 01 Rhag 2008
Digwyddiad	Winter Meeting of the British-Thoracic-Society - London, Teyrnas Unedig Prydain Fawr a Gogledd Iwerddon Hyd: 03 Rhag 2008 → 05 Rhag 2008

Cynhadledd

Cynhadledd	Winter Meeting of the British-Thoracic-Society
Gwlad/Tiriogaeth	Teyrnas Unedig Prydain Fawr a Gogledd Iwerddon
Dinas	London
Cyfnod	03 Rhag 2008 → 05 Rhag 2008

NDC y CU

Mae’r allbwn hwn yn cyfrannu at y Nod(au) Datblygu Cynaliadwy canlynol

Mynediad at Ddogfen

http://hdl.handle.net/2160/2410

Cysylltiad parhaol

Dolen barhaus

Dyfynnu hyn

@inproceedings{14e7fd5fd74b4ec08725d8dc889b7fb2,

title = "Fourier transform infrared spectroscopy and metabolic profiling in lung cancer",

abstract = "Introduction: We have shown that sputum is a feasible biofluid for analysis of biomarkers using Fourier transform infrared (FTIR) spectroscopic analysis and that FTIR can detect different patterns of metabolites between patients with lung cancer and healthy volunteers.1 Aim: To analyse further the FTIR spectrometric patterns in more patients with lung cancer and also smokers deemed 'high risk'. To identify what actual compounds may differentiate cancer from non-cancer sputum samples. Methods: Loco-regional ethical permission was obtained.",

author = "P. Kloer and R. Ghosal and Mur, {Luis Alejandro Jose} and Lewis, {K. E.} and Lewis, {P. D.}",

note = "Mur, L. A. J., Kloer, P., Ghosal, R., Lewis, K. E., Lewis, P. D. (2008). Fourier transform infrared spectroscopy and metabolic profiling in lung cancer. Thorax, 63, (Suppl. 7), A60-A61. Spoken session, Winter Meeting of the British Thoracic Society London, UK, 3-5 December, 2008. Thorax, 63 (7) A60-A61 ; Winter Meeting of the British-Thoracic-Society ; Conference date: 03-12-2008 Through 05-12-2008",

year = "2008",

month = dec,

day = "1",

language = "English",

pages = "A60--A61",

booktitle = "Winter Meeting of the British-Thoracic-Society",

}

TY - GEN

T1 - Fourier transform infrared spectroscopy and metabolic profiling in lung cancer

AU - Kloer, P.

AU - Ghosal, R.

AU - Mur, Luis Alejandro Jose

AU - Lewis, K. E.

AU - Lewis, P. D.

N1 - Mur, L. A. J., Kloer, P., Ghosal, R., Lewis, K. E., Lewis, P. D. (2008). Fourier transform infrared spectroscopy and metabolic profiling in lung cancer. Thorax, 63, (Suppl. 7), A60-A61. Spoken session, Winter Meeting of the British Thoracic Society London, UK, 3-5 December, 2008. Thorax, 63 (7) A60-A61

PY - 2008/12/1

Y1 - 2008/12/1

N2 - Introduction: We have shown that sputum is a feasible biofluid for analysis of biomarkers using Fourier transform infrared (FTIR) spectroscopic analysis and that FTIR can detect different patterns of metabolites between patients with lung cancer and healthy volunteers.1 Aim: To analyse further the FTIR spectrometric patterns in more patients with lung cancer and also smokers deemed 'high risk'. To identify what actual compounds may differentiate cancer from non-cancer sputum samples. Methods: Loco-regional ethical permission was obtained.

AB - Introduction: We have shown that sputum is a feasible biofluid for analysis of biomarkers using Fourier transform infrared (FTIR) spectroscopic analysis and that FTIR can detect different patterns of metabolites between patients with lung cancer and healthy volunteers.1 Aim: To analyse further the FTIR spectrometric patterns in more patients with lung cancer and also smokers deemed 'high risk'. To identify what actual compounds may differentiate cancer from non-cancer sputum samples. Methods: Loco-regional ethical permission was obtained.

M3 - Conference Proceeding (Non-Journal item)

SP - A60-A61

BT - Winter Meeting of the British-Thoracic-Society

T2 - Winter Meeting of the British-Thoracic-Society

Y2 - 3 December 2008 through 5 December 2008

ER -

Fourier transform infrared spectroscopy and metabolic profiling in lung cancer

Crynodeb

Cynhadledd

NDC y CU

Mynediad at Ddogfen

Cysylltiad parhaol

Ôl bys

Dyfynnu hyn